From: Prognostic value of inflammation-based indices in patients with resected hepatocellular carcinoma
Variable | Univariate analysis | Multivariate analysis | ||||
---|---|---|---|---|---|---|
p | Hazard ratio | 95%confidence interval | p | Hazard ratio | 95%confidence interval | |
Age (years)(≥60 versus < 60) | 0.355 | 0.819 | 0.537–1.250 | |||
Gender (female versus male) | 0.437 | 0.783 | 0.422–1.452 | |||
HBsAg (yes versus no) | 0.345 | 1.306 | 0.750–2.274 | |||
Cirrhosis (yes versus no) | 0.405 | 1.154 | 0.823–1.618 | |||
Tumor size (> 5 versus ≤5) | < 0.001 | 2.332 | 1.650–3.296 | – | ||
Tumor number (multiple versus single) | < 0.001 | 2.198 | 1.551–3.114 | 0.014 | 1.599 | 1.101–2.323 |
AFP(≥400 versus < 400) | 0.044 | 1.452 | 1.010–2.087 | 0.042 | 1.471 | 1.014–2.135 |
Vascular invasion (yes versus no) | < 0.001 | 2.095 | 1.485–2.955 | – | ||
Child-Pugh grade (B versus A) | 0.067 | 1.746 | 0.963–3.166 | |||
BCLC Stage(B + C versus 0 + A) | < 0.001 | 2.893 | 1.932–4.332 | 0.001 | 2.078 | 1.333–3.238 |
Differentiation (poor versus well/moderate) | 0.112 | 1.568 | 0.900–2.730 | |||
PT (≥13.7 versus < 13.7) | 0.326 | 0.841 | 0.595–1.188 | |||
ALT (≥ 34 versus < 34) | 0.100 | 1.347 | 0.944–1.920 | |||
TB (≥12.5 versus < 12.5) | 0.889 | 1.026 | 0.719–1.463 | |||
GGT (≥49 versus < 49) | < 0.001 | 2.084 | 1.431–3.036 | 0.006 | 1.714 | 1.163–2.526 |
ALB (≥39.0 versus < 39.0) | 0.437 | 0.871 | 0.616–1.233 | |||
MPV (≥11.2 versus < 11.2) | 0.228 | 1.257 | 0.867–1.822 | |||
co NLR-PDW | < 0.001 | 2.292 | 1.737–3.024 | < 0.001 | 2.370 | 1.781–3.152 |